Biomerica, Inc.
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are use…
Insiders
Transactions
| Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
|---|---|---|---|---|---|---|---|
|
$188,337
d
Common stock
10% Holder
|
12/13/24 |
A
|
110,000 x $0.31 = $34,100.00 |
Footnotes
#1 Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.
|
|||
|
$128,790
d
Common stock
10% Holder
|
12/13/24 |
A
|
85,000 x $0.31 = $26,350.00 |
Footnotes
#1 Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.
|
|||
|
$1,270,560
d
Common stock
10% Holder
|
12/13/24 |
A
|
250,000 x $0.31 = $77,500.00 |
Footnotes
#1 Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over 4 years at 25% on each anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.
|
|||
|
$156,000
d
Common stock
10% Holder
|
12/13/24 |
A
|
85,000 x $0.31 = $26,350.00 |
Footnotes
#1 Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.
|
|||
|
$85,000
d
Common stock
10% Holder
|
12/13/24 |
A
|
85,000 x $0.31 = $26,350.00 |
Footnotes
#1 Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.
|
|||
Get PRO Today
With PRO you will unlock 20 more insider transactions for Biomerica, Inc.
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture: